Assignee
STEP PHARMA S A S
FR·7 granted patents·7 pending applications·8 citations·filing 2018–2025
Top patents by PatentIndex Score
14 records- 0190US12319680B2CompoundsSTEP PHARMA S A S·Filed 2022·Granted Jun 3, 2025·1 cites·1 claims
- 0288US12371419B2Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitorsSTEP PHARMA S A S·Filed 2024·Granted Jul 29, 2025·1 cites·8 claims
- 0386US11505547B2CompoundsSTEP PHARMA S A S·Filed 2018·Granted Nov 22, 2022·3 cites·20 claims
- 0480US11987573B2Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitorsSTEP PHARMA S A S·Filed 2019·Granted May 21, 2024·2 cites·5 claims
- 0577US12503466B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2023·Granted Dec 23, 2025·0 cites·2 claims
- 0673US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 0770US2025282756A1Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitorsSTEP PHARMA S A S·Filed 2025·Application pending·0 cites
- 0858US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 0957US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 1056US2025177394A1Combinations of ctps1 and bcl2 inhibitors for cancerSTEP PHARMA S A S·Filed 2023·Application pending·0 cites
- 1149US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1248US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1347US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1441US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →